Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Cash flows from operating activities
Net loss	$ (4,442,988)	$ (3,872,575)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment	349,388	171,261
Amortization of intangible assets	380,388	0
Stock-based compensation	644,640	310,788
Equity in loss of investee company	58,710	0
Changes in assets and liabilities
Accounts receivable	(189,616)	6,879
Inventories	(1,151,633)	(69,854)
Prepaids and other current assets	(87,896)	(180,463)
Refundable income taxes	47,450	0
Accounts payable	904,531	143,363
Accrued compensation and benefits	(169,134)	(221,153)
Accrued expenses	(206,541)	(79,034)
Deferred revenues	308,516	214,511
Net cash used in operating activities	(3,554,185)	(3,576,277)
Cash flows from investing activities
Expenditures for property and equipment	(1,307,927)	(318,310)
Investment in investee company	(1,640,728)	0
Net cash used in investing activities	(2,948,655)	(318,310)
Cash flows from financing activities
Proceeds from bank loans and notes payable	0	1,300,000
Repayments of bank loans and notes payable	(151,867)	(219,501)
Proceeds from issuance of debenture notes payable	0	517,168
Proceeds from issuance of Series A preferred stock	2,197,240	490,000
Proceeds from issuance of Common Stock	1,887,398	1,174,187
Common stock issuance costs	(176,934)	0
Proceeds from noncontrolling interest	1,546,062	0
Net cash provided by financing activities	5,301,899	3,261,854
Effect of exchange rate changes on cash and cash equivalents	(29,111)	8,587
Net decrease in cash and cash equivalents	(1,230,052)	(624,146)
Cash and cash equivalents - beginning of period	2,910,595	1,235,635
Cash and cash equivalents - end of period	1,680,543	611,489
Cash paid for interest	105,451	26,749
Cash received for income tax credit	223,703	0
Supplemental schedule of non-cash investing and financing activities:
Conversion of debenture notes payable to Series A preferred stock	0	524,678
Issuance of common stock for discounted notes receivable	2,187,330	1,001,883
Issuance of common stock as consideration for equity issuance costs	0	683,634
Conversion of cash settled RSUs to stock settled RSUs	$ 0	$ 315,833
Issuance of warrants for purchase of property and equipment	0	11,834